Oligo-G

N/A

Report date: 2026/03/31 20:00:21

NME

Base Information

Drug NameOligo-G

Drug Alias NameOligosaccharide nanotherapeutic - AlgiPharmaOligoG CF-5/20Alginate oligosaccharide (G-block) fragmentOligoG-COPD-5/20Oligo- COPD-10/20(1) +[6]

ClassificationSmall molecules > Carbohydrate

Mechanisms of ActionBacterial growth inhibitors

TargetsNot applicable

Therapy Area/IndicationsCystic FibrosisBurkholderia Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwedenNorwayDenmark +[7]

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNorwegian University Of Science And Technology

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAlgipharma As

Active IndicationsN/A

Inactive IndicationsCystic FibrosisBurkholderia Infections

Other Information

ATC CodeN/A